Compare DexCom, Inc. (DXCM) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Tencent Music Entertainment Group - ADR — how do they compare? DexCom, Inc. trades at $90.64 (market cap $33.79B), while Tencent Music Entertainment Group - ADR trades at $8.46 (market cap $16.09B). The key difference: DexCom, Inc. is far larger — about 2.1× Tencent Music Entertainment Group - ADR's market cap, and Tencent Music Entertainment Group - ADR pays a 2.75% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | TME | |
|---|---|---|
Market Cap | $33.79B | $16.09B |
Sector | Health | Media |
52-Week High | $89.53 | $26.36 |
52-Week Low | $54.84 | $8.16 |
Enterprise Value | $33.24B | $14.05B |
Dividend Yield | — | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $91.00, up 3.82% today and near its 52-week high, with bullish technical signals from moving averages and strong fundamentals. Recent Q2 2026 earnings beat expectations with EPS of $0.70 versus $0.61 expected, driven by 13% revenue growth and margin expansion. The company raised full-year 2026 guidance, reflecting robust demand for continuous glucose monitors.
The outlook is positive due to sustained revenue growth, profitability improvements, and analyst consensus favoring buys. Risks include competitive pressures and potential regulatory scrutiny, but institutional ownership trends and earnings momentum support a constructive view for investors seeking exposure to medical technology.
TME stock trades at $8.45, down 14.65% in the last session amid mixed earnings results. The company reported Q2 2026 revenue growth of 6% year-over-year but faces slowing operational growth and competitive pressures. Valuation metrics appear reasonable with a P/E of 10.29 and P/S of 2.71, while profitability remains strong with a net income margin of 26.28%. Technical indicators signal a bearish trend, with the stock near key support levels.
The outlook is cautious; while TME's fundamentals are solid with robust cash flow and profitability, near-term headwinds from competition and market sentiment pose risks. Analyst consensus is divided, with 46% buy ratings but 50% hold, reflecting uncertainty over growth sustainability. Investors should weigh the attractive valuation against execution risks in a challenging environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
